MGCD516,
sitravatinib,
Sitravatinib,
1123837-84-2,
MGCD516,
MG-516,
Sitravatinib (MGCD516),
UNII-CWG62Q1VTB,
CWG62Q1VTB,
1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N'-(4- fluorophenyl)-,
Sitravatinib [INN],
Sitravatinib (USAN/INN),
Sitravatinib [USAN:INN],
SCHEMBL172015,
GCD516,
GTPL9920,
CHEMBL3989926,
GCD-516,
MG516,
BCP29099,
EX-A2588,
s8573,
AKOS030526257,
ZINC164334830,
CS-5652,
SB17195,
NCGC00483926-01,
AK547008,
HY-16961,
D11140,
MGCD516;MGCD-516;MGCD 516;MG516;MG 516;MG-516,
1,1-Cyclopropanedicarboxamide, N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)-2-pyridinyl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N'-(4-fluorophenyl)-,
1-N'-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,
1609655-67-5,
N-(3-Fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,
A16259,
N-(3-fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,